Integra LifeSciences Holdings Corporation IART
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 311.93M | 274.08M | 265.50M | 263.74M | 267.88M |
| Total Receivables | 248.99M | 267.19M | 264.41M | 278.85M | 262.16M |
| Inventory | 464.45M | 492.01M | 495.04M | 492.74M | 489.11M |
| Prepaid Expenses | 117.62M | 104.34M | 97.71M | 96.09M | 94.11M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 46.94M | 53.86M | 49.35M | 28.13M | 30.33M |
| Total Current Assets | 1.19B | 1.19B | 1.17B | 1.16B | 1.14B |
|
|
|||||
| Total Current Assets | 1.19B | 1.19B | 1.17B | 1.16B | 1.14B |
| Net Property, Plant & Equipment | 577.27M | 583.29M | 584.08M | 584.90M | 575.55M |
| Long-term Investments | 607.83M | 611.15M | 613.25M | 615.16M | 615.20M |
| Goodwill | 607.83M | 611.15M | 613.25M | 615.16M | 615.20M |
| Total Other Intangibles | 1.04B | 1.08B | 1.11B | 1.13B | 1.16B |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 85.79M | 92.38M | 90.89M | 94.99M | 136.43M |
| Total Assets | 3.51B | 3.56B | 3.58B | 3.60B | 3.65B |
|
|
|||||
| Total Accounts Payable | 66.42M | 82.64M | 87.95M | 95.73M | 92.31M |
| Total Accrued Expenses | 151.18M | 160.36M | 181.63M | 164.50M | 200.03M |
| Short-term Debt | -- | -- | -- | 87.80M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 63.96M | 58.50M | 53.72M | 53.87M | 53.72M |
| Total Finance Division Other Current Liabilities | 47.45M | 29.38M | 23.55M | 54.09M | 18.00M |
| Total Other Current Liabilities | 47.45M | 29.38M | 23.55M | 54.09M | 18.00M |
| Total Current Liabilities | 329.00M | 330.88M | 346.85M | 455.98M | 364.05M |
|
|
|||||
| Total Current Liabilities | 329.00M | 330.88M | 346.85M | 455.98M | 364.05M |
| Long-Term Debt | 1.78B | 1.83B | 1.83B | 1.73B | 1.79B |
| Short-term Debt | -- | -- | -- | 87.80M | -- |
| Capital Leases | 161.09M | 162.66M | 160.12M | 163.06M | 160.93M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 172.88M | 197.62M | 201.32M | 209.42M | 290.82M |
| Total Liabilities | 2.44B | 2.52B | 2.54B | 2.56B | 2.61B |
|
|
|||||
| Common Stock & APIC | 1.35B | 1.35B | 1.34B | 1.34B | 1.33B |
| Retained Earnings | 438.16M | 423.31M | 418.82M | 423.44M | 425.15M |
| Treasury Stock & Other | -718.60M | -727.12M | -718.06M | -719.29M | -722.00M |
| Total Common Equity | 1.07B | 1.04B | 1.04B | 1.04B | 1.04B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.07B | 1.04B | 1.04B | 1.04B | 1.04B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.07B | 1.04B | 1.04B | 1.04B | 1.04B |
|
|
|||||